Hyperprogressive disease during nivolumab chemotherapy in metastatic gastric cancer: Multicenter retrospective study in Japan. Comparing five-weekly S-1 plus cisplatin with tri-weekly capecitabine ...
HGCSG 1603: Phase II study of ramucirumab and irinotecan combination therapy as second-line treatment in patients with metastatic or advanced gastric cancer. Background: Proximal gastrectomy (PG) is ...
Please provide your email address to receive an email when new articles are posted on . “Open gastrectomy has long been the criterion standard worldwide. However, application of laparoscopic ...
Laparoscopic sleeve gastrectomy surgery limits how much food your stomach can hold and how much nutrition your body can absorb. Laparoscopic sleeve gastrectomy (LSG) surgery — also known as vertical ...
WASHINGTON, DC — Two new studies help better characterize the short- and long-term outcomes for laparoscopic sleeve gastrectomy, which in recent years has become the favored and most commonly ...
The researchers found that the estimated mean percentage weight loss at five years was 49 and 57% after sleeve gastrectomy and gastric bypass, respectively. HealthDay News — For patients with morbid ...
Reply to: Letter to editor on the article "Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy". Development of the PERI-Gastric (PEritoneal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results